Target intelligence / Profile preview

T cell receptor alpha joining 58 (non-functional) (TRAJ58)

Target
TRAJ58
Molecular classification
Other (T cell receptor gene segment), Immune receptor gene segment
01

Overview

T cell receptor alpha joining 58 (TRAJ58) is a gene segment of the T cell receptor alpha (TCRA) locus, specifically classified as a joining (J) segment. These J segments participate in the V-J gene rearrangement process during T cell development in the thymus, generating the diversity of the T cell receptor repertoire by contributing to the coding of the variable region (notably the CDR3 loop) of the TCR alpha chain[10][7]. According to The Human Protein Atlas, TRAJ58 is annotated as a non-functional J segment, which means that it does not encode a functional portion of the TCR when rearranged[4]. As a J gene segment, it is not a traditional therapeutic target such as a receptor protein or enzyme, and there are no drugs known or possible mechanism-of-action entries directly connected to TRAJ58. Rather, its biological function is as a genetic element enabling the generation of the receptor diversity necessary for adaptive immune responses, with its rearrangement levels and usage potentially subject to developmental or selection biases in the thymus[2][10][9].

Other names
TRAJ58TCR alpha joining 58
02

Biological functions

Antigen recognition (via recombination into functional TCR alpha chains)Immune response (indirect, by enabling diversity in TCRs through gene recombination)
03

Disease associations

Other (Altered TCR repertoire can influence immunity and autoimmune risk, but no specific direct disease association for TRAJ58 itself)

Beyond the preview

Go deeper on T cell receptor alpha joining 58 (non-functional) (TRAJ58).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor alpha joining 58 (non-functional) (TRAJ58).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call